Reckitt Benckiser Group plc (LON:RKT - Get Free Report) rose 0.5% during trading on Thursday . The stock traded as high as GBX 4,890 ($60.75) and last traded at GBX 4,858.61 ($60.36). Approximately 469,236 shares were traded during mid-day trading, a decline of 84% from the average daily volume of 3,023,673 shares. The stock had previously closed at GBX 4,833 ($60.04).
Wall Street Analyst Weigh In
Separately, Berenberg Bank cut their target price on shares of Reckitt Benckiser Group from GBX 5,200 ($64.60) to GBX 5,177 ($64.31) and set a "hold" rating for the company in a research note on Wednesday, October 23rd.
Get Our Latest Report on RKT
Reckitt Benckiser Group Trading Up 0.2 %
The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 112.52. The company has a fifty day moving average price of GBX 4,822.18 and a two-hundred day moving average price of GBX 4,565.42. The firm has a market capitalization of £33.65 billion, a price-to-earnings ratio of 2,243.78, a PEG ratio of 1.10 and a beta of 0.09.
Insider Activity
In related news, insider Fiona Dawson acquired 25 shares of the firm's stock in a transaction dated Wednesday, October 23rd. The shares were purchased at an average cost of GBX 4,923 ($61.16) per share, for a total transaction of £1,230.75 ($1,528.88). Also, insider Shannon Eisenhardt sold 1,368 shares of Reckitt Benckiser Group stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of GBX 4,723 ($58.67), for a total transaction of £64,610.64 ($80,261.66). Corporate insiders own 0.05% of the company's stock.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
